Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 2022.

MLA

Petrie, Joshua G., et al. “Effectiveness of First and Second COVID‐19 MRNA Vaccine Monovalent Booster Doses during a Period of Circulation of Omicron Variant Sublineages: December 2021–July 2022.” Influenza & Other Respiratory Viruses, vol. 17, no. 3, Mar. 2023, pp. 1–10. EBSCOhost, https://doi.org/10.1111/irv.13104.

APA

Petrie, J. G., King, J. P., McClure, D. L., Rolfes, M. A., Meece, J. K., Pattinson, D., Neumann, G., Kawaoka, Y., Belongia, E. A., & McLean, H. Q. (2023). Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 2022. Influenza & Other Respiratory Viruses, 17(3), 1–10. https://doi.org/10.1111/irv.13104

Chicago

Petrie, Joshua G., Jennifer P. King, David L. McClure, Melissa A. Rolfes, Jennifer K. Meece, David Pattinson, Gabriele Neumann, Yoshihiro Kawaoka, Edward A. Belongia, and Huong Q. McLean. 2023. “Effectiveness of First and Second COVID‐19 MRNA Vaccine Monovalent Booster Doses during a Period of Circulation of Omicron Variant Sublineages: December 2021–July 2022.” Influenza & Other Respiratory Viruses 17 (3): 1–10. doi:10.1111/irv.13104.